Route 206 & Province Line Road
Princeton, NJ 08543
United States
609 252 4621
https://www.bms.com
Setor(es): Healthcare
Indústria: Drug Manufacturers - General
Funcionários Integrais: 34.100
Nome | Título | Pagar | Exercido | Nascido em |
---|---|---|---|---|
Dr. Christopher S. Boerner Ph.D. | CEO & Chairman | 16,42M | N/A | 1971 |
Mr. David V. Elkins | Executive VP & CFO | 11,96M | N/A | 1968 |
Ms. Sandra Leung Esq. | Executive VP & General Counsel | 13,5M | N/A | 1961 |
Mr. Samit Hirawat M.D. | Executive VP, Chief Medical Officer & Head of Development | 13,7M | N/A | 1969 |
Mr. Greg Meyers | Executive VP and Chief Digital & Technology Officer | N/A | N/A | 1973 |
Mr. Timothy Power | VP & Head of Investor Relations | N/A | N/A | N/A |
Ms. Kimberly M. Jablonski | Chief Compliance & Ethics Officer | N/A | N/A | N/A |
Ms. Ahn Amanda Poole | Executive Vice President & Chief Human Resources Officer | N/A | N/A | 1975 |
Dr. Joseph J. Eiden Jr. | Head of Medical Affairs | N/A | N/A | 1949 |
Mr. Adam Lenkowsky | Executive VP, Chief Commercialization Officer & Head of U.S. Oncology | N/A | N/A | 1972 |
O QualityScore de governança da ISS da Bristol-Myers Squibb Company a partir de 1 de abril de 2024 é 2. As principais pontuações para Auditoria são: 5; Conselho: 6; Direitos de Acionistas: 2; Compensação: 1.